Gilead Sciences
GILD
GILD
1,863 hedge funds and large institutions have $98.3B invested in Gilead Sciences in 2024 Q4 according to their latest regulatory filings, with 285 funds opening new positions, 640 increasing their positions, 717 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,863
Holders Change
+163
Holders Change %
+9.59%
% of All Funds
24.8%
Holding in Top 10
28
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+55.56%
% of All Funds
0.37%
New
285
Increased
640
Reduced
717
Closed
92
Calls
$864M
Puts
$959M
Net Calls
-$94.5M
Net Calls Change
-$124M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$969M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$661M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$522M |
| 4 |
Bank of New York Mellon
New York
|
+$261M |
| 5 |
Morgan Stanley
New York
|
+$261M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$447M |
| 2 |
Amundi
Paris,
France
|
-$410M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$356M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$264M |
| 5 |
Two Sigma Advisers
New York
|
-$205M |
